Allogene Therapeutics jobs and careers
South San Francisco, CA, United States
About Allogene Therapeutics
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.
- Employees
- 350
- Headquarters
- South San Francisco
Leadership
The top of Allogene Therapeutics's org chart, with how many people report into each leader.
David Chang
Board Member, Allogene Therapeutics
130 reports
Geoffrey Parker
Executive Vice President And Chief Financial Officer
57 reports
Zachary J Roberts M.D.
Executive Vice President Of Research & Development And Chief Medical Officer
36 reports
Zachary J. Roberts
EVP, Research & Development & CMO
14 reports
Ben Beneski
Chief Technical Officer (cto)
11 reports
Susan Lundeen
Chief People Officer
5 reports
Christine Cassiano
Evp, Chief Corporate Affairs & Brand Strategy Officer
1 report
Board
Stephen J. Forman
Scientific Advisor
Debbie Messemer
Board Member
Owen Witte
Scientific Advisor & Board Member
Thomas F. Gajewski
Scientific Advisor
Malcolm K. Brenner
Scientific Advisor
Matthew Porteus
Scientific Advisor
Jobs at Allogene Therapeutics
No open positions right now. Explore more companies on TheJobsMap.